Open AccessWhat should we consider besides immune checkpoint drugs on the way to improvement of the efficacy?
Author(s) -
F.V. Moiseenko
Publication year - 2022
Publication title -
praktičeskaâ onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 1726-9830
pISSN - 1726-9814
DOI - 10.31917/2302072
Subject(s) - immune system , systemic inflammation , inflammation , immune checkpoint , tumor microenvironment , homeostasis , microbiome , immunology , medicine , cancer research , biology , immunotherapy , bioinformatics , microbiology and biotechnology